Medicinal attributes of pyrazolo[3,4-d]pyrimidines: A review
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boolell, M., Mj, A., Sa, B., Gepi-Attee, S., Muirhead, G. J., Naylor, A. M., Ih, O., & Gingell, C. (1996) · PubMed · Cited by 1,067
Terrett, N. K., Bell, A. S., Brown, D., & Ellis, P. (1996) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(96)00323-x · Cited by 607
Sildenafil, a novel effective oral therapy for male erectile dysfunction
Boolell, M., Gepi‐Attee, S., Gingell, J. C., & Allen, M. J. (1996) · British Journal of Urology · doi:10.1046/j.1464-410x.1996.10220.x · Cited by 564
Zaleplon: a pyrazolopyrimidine sedative-hypnotic agent for the treatment of insomnia
Weitzel, K. W., Wickman, J. M., Augustin, S. G., & Strom, J. G. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)83024-6 · Cited by 246
Synthesis and SAR of a New Series of COX-2-Selective Inhibitors: Pyrazolo[1,5-a]pyrimidines
Almansa, C., de Arriba, A. F., Cavalcanti, F. L., Gómez, L. A., Miralles, A., Merlos, M., García-Rafanell, J., & Forn, J. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0009383 · Cited by 175
Ghorab, M. M., Ragab, F. A.-F., Alqasoumi, S. I., Alafeefy, A. M., & Aboulmagd, S. A. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2009.09.039 · Cited by 159
Petroski, R. E., Pomeroy, J. E., Das, R., Bowman, H., Yang, W., Chen, A. P., & Foster, A. C. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.096701 · Cited by 128
Chern, J., Shia, K., Hsu, T., Tai, C., Lee, C.-C., Lee, Y., Chang, C., Tseng, S., & Shih, S. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(04)00309-9 · Cited by 123
Xanthine oxidase inhibitors: a patent survey
Kumar, R., Darpan, Sharma, S., & Singh, R. (2011) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2011.577417 · Cited by 116
Self-citationCarraro, F., Naldini, A., Pucci, A., Locatelli, G. A., Maga, G., Schenone, S., Bruno, O., Ranise, A., Bondavalli, F., Brullo, C., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050603r · Cited by 97
Manetti, F., Santucci, A., Locatelli, G. A., Maga, G., Spreafico, A., Serchi, T., Orlandini, M., Bernardini, G., Caradonna, N. P., Spallarossa, A., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061449r · Cited by 93
Rashad, A. E., Mahmoud, A. E. E.-D., & Ali, M. M. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.01.013 · Cited by 93
Synthesis of N-aryl-5-amino-4-cyanopyrazole derivatives as potent xanthine oxidase inhibitors
Gupta, S. D., Rodrigues, L. M., Esteves, A. P., Oliveira‐Campos, A. M. F., Nascimento, M. S. J., Nazareth, N., Cidade, H. M., Neves, M. P., Fernandes, E. G. R., & Pinto, M. M. M. (2007) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2007.06.002 · Cited by 92
Radi, M., Dreassi, E., Brullo, C., Crespan, E., Tintori, C., Bernardo, V., Valoti, M., Zamperini, C., Daigl, H., Musumeci, F., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1012819 · Cited by 89
Zaleplon pharmacokinetics and absolute bioavailability
Rosen, A. S., Fournié, P., Darwish, M., Danjou, P., & Troy, S. M. (1999) · Biopharmaceutics & Drug Disposition · doi:10.1002/(sici)1099-081x(199904)20:3<171::aid-bdd169>3.0.co;2-k · Cited by 83
Manetti, F., Brullo, C., Magnani, M., Mosci, F., Chelli, B., Crespan, E., Schenone, S., Naldini, A., Bruno, O., Trincavelli, M. L., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701240c · Cited by 81
Angelucci, A., Schenone, S., Gravina, G. L., Muzi, P., Festuccia, C., Vicentini, C., Botta, M., & Bologna, M. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.06.024 · Cited by 79
Spreafico, A., Schenone, S., Serchi, T., Orlandini, M., Angelucci, A., Magrini, D., Bernardini, G., Collodel, G., Di Stefano, A., Tintori, C., et al. (2008) · The FASEB Journal · doi:10.1096/fj.07-9873com · Cited by 63
Celano, M., Schenone, S., Cosco, D., Navarra, M., Puxeddu, E., Racanicchi, L., Brullo, C., Varano, E., Alcaro, S., Ferretti, E., et al. (2008) · Endocrine Related Cancer · doi:10.1677/erc-07-0243 · Cited by 61
Non-xanthine heterocycles: Activity as antagonists of A1 and A2-adenosine receptors
Daly, J. W., Hong, O., Padgett, W. L., Shamim, M. T., Jacobson, K. A., & Ukena, D. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90139-6 · Cited by 60
Kaplan, J. A., Verheijen, J. C., Brooijmans, N., Toral‐Barza, L., Hollander, I. J., Yu, K., & Zask, A. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.11.050 · Cited by 53
Synthesis and anti-tubercular evaluation of some novel pyrazolo[3,4-d]pyrimidine derivatives
Trivedi, A. R., Dholariya, B. H., Vakhariya, C. P., Dodiya, D. K., Ram, H. K., Kataria, V. B., Siddiqui, A. B., & Shah, V. H. (2011) · Medicinal Chemistry Research · doi:10.1007/s00044-011-9712-3 · Cited by 52
Facile One‐Pot Synthesis and Antimycobacterial Evaluation of Pyrazolo[3,4‐d]pyrimidines
Trivedi, A. R., Dodiya, D. K., Surani, J., Jarsania, S., Mathukiya, H., Ravat, N., & Shah, V. H. (2008) · Archiv der Pharmazie · doi:10.1002/ardp.200800027 · Cited by 51
Yang, L., Li, G., Yan, H., Sun, Q., Ma, S., Ji, P., Wang, Z.-R., Feng, S., Zou, J., & Yang, S. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.08.007 · Cited by 49
Motta, C. L., Sartini, S., Mugnaini, L., Salerno, S., Simorini, F., Taliani, S., Marini, A. M., Settimo, F. D., Lavecchia, A., Novellino, E., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801427r · Cited by 46
Beer, B., Clody, D. E., Mangano, R., Levner, M., Mayer, P., & Barrett, J. E. (1997) · CNS Drug Reviews · doi:10.1111/j.1527-3458.1997.tb00324.x · Cited by 40
Brazidec, J. L., Pasis, A., Tam, B. Y. Y., Boykin, C., Black, C., Wang, D., Claassen, G. F., Chong, J.-H., Chao, J., Fan, J., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.01.019 · Cited by 40
Kopecky, D. J., Hao, X., Chen, Y., Fu, J., Jiao, X., Jaén, J. C., Cardozo, M. G., Liu, J., Wang, Z., Walker, N. P. C., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.10.092 · Cited by 37
Rossi, A., Schenone, S., Angelucci, A., Cozzi, M., Caracciolo, V., Pentimalli, F., Puca, A., Pucci, B., Montagna, R. L., Bologna, M., et al. (2010) · The FASEB Journal · doi:10.1096/fj.09-148593 · Cited by 34
Negi, A., Ramarao, P., & Kumar, R. (2013) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557511313050004 · Cited by 33
Self-citationPyrazolopyrimidines as dual Akt/p70S6K inhibitors
Rice, K. D., Kim, M. H., Bussenius, J., Anand, N. K., Blazey, C. M., Bowles, O. J., Bannen, L., Chan, D. S.-M., Chen, B., Co, E. W., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.03.011 · Cited by 28
Wang, G. T., Mantei, R. A., Hubbard, R. D., Wilsbacher, J. L., Zhang, Q., Tucker, L. A., Hu, X., Kovar, P. J., Johnson, E. F., Osterling, D. J., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.08.052 · Cited by 26
Trivedi, A. R., Vaghasia, S., Dholariya, B. H., Dodiya, D. K., & Shah, V. H. (2010) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756360903540276 · Cited by 17
Cited by
Mahajan, A. T., Shivani, Datusalia, A. K., Coluccini, C., Coghi, P., & Chaudhary, S. (2024) · Molecules · doi:10.3390/molecules29153560 · Cited by 12
“…anti-bacterial agents, anti-in fl am-matory agents, anti-cancer agents, anti-fungal agents, antiviral agents, and ligands for estrogen receptors [61,62]. system (CNS) agents, anti-bacterial agents, anti-inflammatory agents, anti-cancer agents, anti-fungal agents, antiviral agents, and ligands for…”
Background
Metadata
- Authors
- Chauhan, M., & Kumar, R.
- Venue
- Bioorganic & Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2013-09
- Volume
- 21
- Issue
- 18
- Pages
- 5657-5668
- ISSN
- 0968-0896 (ISSN-L)
- OpenAlex
- W2074308723
- Cited by
- 168
- References
- 33
- FWCI
- 6.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.